An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants

The wide transmission and host adaptation of SARS-CoV-2 have led to the rapid accumulation of mutations, posing significant challenges to the effectiveness of vaccines and therapeutic antibodies. Although several neutralizing antibodies were authorized for emergency clinical use, convalescent patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Xiaojing, Zhang, Xinhui, Pan, Shengnan, Yu, Yanying, Shi, Yujin, Lin, Tianli, Duan, Huarui, Liu, Xiuying, Chen, Wenfang, Yang, Xuehua, Chen, Lan, Dong, Xiaoqian, Ren, Lili, Ding, Qiang, Wang, Jianwei, Yang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828845/
https://www.ncbi.nlm.nih.gov/pubmed/35140196
http://dx.doi.org/10.1038/s41392-022-00912-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828845/
https://www.ncbi.nlm.nih.gov/pubmed/35140196
http://dx.doi.org/10.1038/s41392-022-00912-4

Ejemplares similares